159 related articles for article (PubMed ID: 8807569)
21. Increased parathyroid expression of klotho in uremic rats.
Hofman-Bang J; Martuseviciene G; Santini MA; Olgaard K; Lewin E
Kidney Int; 2010 Dec; 78(11):1119-27. PubMed ID: 20631679
[TBL] [Abstract][Full Text] [Related]
22. Novel, selective vitamin D analog suppresses parathyroid hormone in uremic animals and postmenopausal women.
Zella JB; Plum LA; Plowchalk DR; Potochoiba M; Clagett-Dame M; DeLuca HF
Am J Nephrol; 2014; 39(6):476-83. PubMed ID: 24854296
[TBL] [Abstract][Full Text] [Related]
23. Direct maxacalcitol injection into hyperplastic parathyroids improves skeletal changes in secondary hyperparathyroidism.
Shiizaki K; Hatamura I; Negi S; Sakaguchi T; Saji F; Kunimoto K; Okamoto M; Imazeki I; Muragaki Y; Akizawa T
Kidney Int; 2006 Aug; 70(3):486-95. PubMed ID: 16788697
[TBL] [Abstract][Full Text] [Related]
24. 1,25-Dihydroxyvitamin D3 receptors in peripheral blood mononuclear cells from patients with renal insufficiency.
Olmos JM; Martínez J; de Francisco AL; Riancho JA; Amado JA; González-Macías J
Methods Find Exp Clin Pharmacol; 1998 Oct; 20(8):699-707. PubMed ID: 9922985
[TBL] [Abstract][Full Text] [Related]
25. Organ distribution of aluminium in uremic rats: influence of parathyroid hormone and 1,25-dihydroxyvitamin D3.
Hirschberg R; von Herrath D; Voss R; Bossaller W; Mauelshagen U; Pauls A; Schaefer K
Miner Electrolyte Metab; 1985; 11(2):106-10. PubMed ID: 3838793
[TBL] [Abstract][Full Text] [Related]
26. Reduced parathyroid vitamin D receptor messenger ribonucleic acid levels in primary and secondary hyperparathyroidism.
Carling T; Rastad J; Szabó E; Westin G; Akerström G
J Clin Endocrinol Metab; 2000 May; 85(5):2000-3. PubMed ID: 10843188
[TBL] [Abstract][Full Text] [Related]
27. FGF23 fails to inhibit uremic parathyroid glands.
Canalejo R; Canalejo A; Martinez-Moreno JM; Rodriguez-Ortiz ME; Estepa JC; Mendoza FJ; Munoz-Castaneda JR; Shalhoub V; Almaden Y; Rodriguez M
J Am Soc Nephrol; 2010 Jul; 21(7):1125-35. PubMed ID: 20431039
[TBL] [Abstract][Full Text] [Related]
28. Regulation of intestinal vitamin D receptor expression in experimental uraemia: effects of parathyroidectomy and administration of PTH.
Szabó A; Schmutz A; Pesian S; Schmidt-Gayk H; Ritz E; Reichel H
Nephrol Dial Transplant; 1998 Feb; 13(2):340-9. PubMed ID: 9509444
[TBL] [Abstract][Full Text] [Related]
29. Development of parathyroid gland hyperplasia without uremia: role of dietary calcium and phosphate.
Canalejo A; Canalejo R; Rodriguez ME; Martinez-Moreno JM; Felsenfeld AJ; Rodríguez M; Almaden Y
Nephrol Dial Transplant; 2010 Apr; 25(4):1087-97. PubMed ID: 19934096
[TBL] [Abstract][Full Text] [Related]
30. Parathyroid hormone and 1,25-dihydroxyvitamin D3 affect the tissue concentrations of zinc in uremic rats.
Hirschberg R; von Herrath D; Voss K; Bosaller W; Mauelshagen U; Pauls A; Schaefer K
Nephron; 1985; 39(3):277-9. PubMed ID: 3838368
[TBL] [Abstract][Full Text] [Related]
31. Cardiac effect of vitamin D receptor modulators in uremic rats.
Mizobuchi M; Ogata H; Yamazaki-Nakazawa A; Hosaka N; Kondo F; Koiwa F; Kinugasa E; Shibata T
J Steroid Biochem Mol Biol; 2016 Oct; 163():20-7. PubMed ID: 27072785
[TBL] [Abstract][Full Text] [Related]
32. Interaction between calcium and 1,25-dihydroxyvitamin D3 in the regulation of preproparathyroid hormone and vitamin D receptor messenger ribonucleic acid in avian parathyroids.
Russell J; Bar A; Sherwood LM; Hurwitz S
Endocrinology; 1993 Jun; 132(6):2639-44. PubMed ID: 8389284
[TBL] [Abstract][Full Text] [Related]
33. Differential regulation of PHEX expression in bone and parathyroid gland by chronic renal insufficiency and 1,25-dihydroxyvitamin D3.
Brewer AJ; Canaff L; Hendy GN; Tenenhouse HS
Am J Physiol Renal Physiol; 2004 Apr; 286(4):F739-48. PubMed ID: 14693675
[TBL] [Abstract][Full Text] [Related]
34. Reduced binding of [3H]1,25-dihydroxyvitamin D3 in the parathyroid glands of patients with renal failure.
Korkor AB
N Engl J Med; 1987 Jun; 316(25):1573-7. PubMed ID: 3035373
[TBL] [Abstract][Full Text] [Related]
35. Metabolism of 22-oxacalcitriol by a vitamin D-inducible pathway in cultured parathyroid cells.
Brown AJ; Berkoben M; Ritter C; Kubodera N; Nishii Y; Slatopolsky E
Biochem Biophys Res Commun; 1992 Dec; 189(2):759-64. PubMed ID: 1472047
[TBL] [Abstract][Full Text] [Related]
36. Salt concentration determines 1,25-dihydroxyvitamin D3 dependency of vitamin D receptor-retinoid X receptor--vitamin D-responsive element complex formation.
Kimmel-Jehan C; Jehan F; DeLuca HF
Arch Biochem Biophys; 1997 May; 341(1):75-80. PubMed ID: 9143355
[TBL] [Abstract][Full Text] [Related]
37. Pathogenesis of secondary hyperparathyroidism.
Slatopolsky E; Brown A; Dusso A
Kidney Int Suppl; 1999 Dec; 73():S14-9. PubMed ID: 10633458
[TBL] [Abstract][Full Text] [Related]
38. Clinical uses of 22-oxacalcitriol.
Mizobuchi M; Ogata H
Curr Vasc Pharmacol; 2014 Mar; 12(2):324-8. PubMed ID: 23713875
[TBL] [Abstract][Full Text] [Related]
39. Case of a parathyroidectomized patient observed longitudinally by ultrasonography. Relationship between the growth rates and 1,25-dihydroxyvitamin D3 receptor contents in the parathyroid glands.
Chou H; Inaba M; Nishizawa Y; Murano M; Ishimura E; Nishitani H; Kim M; Morii H
Nephron; 1996; 73(4):695-700. PubMed ID: 8856274
[TBL] [Abstract][Full Text] [Related]
40. Vitamin D receptor and analogs.
Dusso AS; Thadhani R; Slatopolsky E
Semin Nephrol; 2004 Jan; 24(1):10-6. PubMed ID: 14730505
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
